Clinician's Roundtable

To give us a better look into how counties and cities across the nation are reacting to the racial disparities in healthcare that were brought into the limelight by the COVID-19 pandemic, Dr. Charles Turck reviews the declaration made by officials in Ohio’s most populated county that racism is a public health crisis.

Join Dr. Anju Peters, clinical allergist and Professor of Medicine at Northwestern University Feinberg School of Medicine, as she discusses the disproportionate prevalence of asthma among select patient populations and how healthcare professionals can better help these patients.

The World Health Organization recently listed antibiotic resistance as one of the biggest threats to global health, causing researchers to search for potential antibiotic candidates to combat this crisis. To find one such candidate, one research team turned to an unexpected source: artificial intelligence.

Here to walk us through the team’s approach and findings is Johnathon Stokes, the lead author of the study that identified a powerful new antibiotic compound.

Adrenoleukodystrophy (ALD) is a rare genetic disorder that when left untreated, can have severe and even fatal consequences. Here to review the available treatment options for these patients is Dr. Maria Escolar, the Director of the Program for the Study of Neurodevelopment in Rare Disorders and a Professor of Pediatrics at the University of Pittsburgh School of Medicine.

Menopause is an inevitable transition in every woman’s life, but what if engaging in a basic physiological need like sex could delay its onset? Researching this potential connection is Megan Arnot, a Ph.D. candidate in the Department of Anthropology at the University College London. As the lead author of the study, she walks us through her findings and the range of factors they investigated, like the type of sexual activity and whether or not women lived with a partner.

The novel coronavirus outbreak that began in late 2019 may be the first global epidemic pronounced in the social media age, with myths and misinformation populating just as quickly and frequently as new cases. But is there any truth behind these claims? Here to shed light on this global health crisis is microbiologist Dr. Charles Gerba.

Even though there currently isn’t a cure for cystic fibrosis, there may finally be hope on the horizon for the more than 70,000 people around the world who are living with this debilitating disease. Joining Dr. Paul Dogramji to talk about the emerging treatment options for cystic fibrosis is Dr. Gregory Sawicki, Director at the Cystic Fibrosis Center and Assistant Professor of Pediatrics at Harvard Medical School.

Although it only affects about one in 18,000 people, the impacts of adrenoleukodystrophy cannot be underestimated. That’s why Dr. Paul Orchard joins Mario Nacinovich to talk about this rare—and fatal—genetic disease, why it’s often underdiagnosed and confused with other conditions, and how we can treat it once we’ve reached an accurate diagnosis.

Psychopharmacology is the study of genetic variations to pinpoint more effective personalized treatments for psychiatric disorders. But with clinicians, industry heads, insurance providers, and regulating agencies all weighing in on this practice and forming varying opinions, what’s the best way to move forward? Here to answer that question and others with Dr. Mimi Secor is Dr. James Potash, a Professor of Psychiatry and Behavioral Sciences and Psychiatrist in Chief at the John Hopkins Department of Psychiatry.

The vaping epidemic is becoming more and more concerning, but could new research prompt people to quit? To find out, Dr. Paul Doghramji speaks with Dr. David Peyton about his recent study that challenges the claim that vaping devices take less of a toll on our health than tobacco smoking.